Linc AB (STO:LINC)

Market Cap	4.30B +9.6%
Revenue (ttm)	-414.00M
Net Income	-399.65M
EPS	-6.90
Shares Out	57.91M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,777
Average Volume	34,201
Open	74.40
Previous Close	74.30
Day's Range	74.40 - 76.10
52-Week Range	58.90 - 83.60
Beta	0.71
RSI	65.43
Earnings Date	Apr 21, 2026

About Linc AB

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.9...

• Industry: Asset Management
• Sector: Financials
• Founded: 1991
• Employees: 2
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: LINC